Archive for January, 2016

Right Turn: In a year of cool tech, regenerative medicine made the list

Author: Erin Sugar, 01/29/16

January is a month of resolutions. Whether it be dieting, exercising or finally taking up that project that you said you would begin a year ago, it is a month that typically sparks improvement. (By the way, how are your visits to the gym going?) While January marks the beginning of a new year and…Read more

Organ transplantation: Using biomaterials to prevent immune rejection

Author: Guest, 01/26/16

Samantha is a PhD student in the Chemical Engineering and Applied Chemistry department at the University of Toronto. She has previously investigated regeneration in a non-mammalian gecko model during an MSc program, and now currently combines stem cell biology and biomaterials to encapsulate and deliver therapeutic cells to the stroke-injured brain. Samantha became interested in…Read more

Right Turn: Regenerative medicine debuts on The Late Show

Author: Stacey Johnson, 01/22/16

Does it seem like regenerative medicine is having its moment in the sun? Last week, the news that GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies, with $20 million coming from the Government of Canada and a matching $20 million coming from GE…Read more

Stem cell community loses a treasured friend

Author: Guest, 01/18/16

Joe Sornberger is Director of Communications Programs for the Canadian Stem Cell Foundation and author of Dreams & Due Diligence: Till and McCulloch’s Stem Cell Discovery and Legacy. This post is published here with his permission. The stem cell community is mourning the loss of one of its most cherished champions, Andrew David Lyall. Mr. Lyall…Read more

Right Turn: New $40M centre will solve cell therapy manufacturing challenges

Author: Stacey Johnson, 01/15/16

It was huge news in Canada on Wednesday (January 13) when the Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare announced their partnership in the development of a new centre for advanced therapeutic cell technologies. GE Healthcare is providing CAD $20 million that the Federal Economic Development Agency for Southern Ontario (FedDev Ontario)…Read more

Gene Therapy To Treat HIV In Clinical Trial

Author: Guest, 01/14/16

John Farrell is a science and technology blogger for Forbes online. John was invited to cover proceedings at the 2015 Till & McCulloch Meetings and this is his second report. This blog also appears on Forbes and is reprinted here with permission. One of the more interesting developments I learned about at the recent Till-McCulloch…Read more

Right Turn: “Rock star” researcher awarded $2.4 million to create new skin

Author: Stacey Johnson, 01/08/16

Jakub Tolar, the University of Minnesota researcher who shared stage time with Pearl Jam’s Eddie Vedder, has been awarded $2.4 million, by the Schulze Family Foundation, to support his work creating new skin for people suffering from burns and skin diseases, such as epidermolysis bullosa (EB). (Michele De Luca and Graziella Pellegrini are also doing…Read more

An interview with bioengineering pioneer Kevin Healy

Author: Hamideh Emrani, 01/05/16

In the fourth in her series on “What drives research in the field of biomaterials?” blogger Hamideh Emrani interviews Professor Kevin E. Healy at the University of California, Berkeley. You can catch up on Hamideh’s earlier interviews here. I met Professor Kevin Healy at the University of California, Berkeley. He is the Jan Fandrianto Distinguished…Read more

Right Turn: Happy New Year to you!

Author: Stacey Johnson, 01/01/16

Thank you, loyal readers, for making 2015 a great year for Signals! All the bloggers here at Signals wish you a very happy 2016. Please keep stopping by to read our content and let us know what you think. We’re grateful that you’re reading us and sharing our content, but we’d also love to know…Read more